-
公开(公告)号:US10961247B2
公开(公告)日:2021-03-30
申请号:US16304798
申请日:2017-06-30
发明人: In Woo Kim , Mi Ryeong Han , Jakyung Yoo , Yun Ju Oh , Ji Duck Kim , Nam Youn Kim , Sun Ah Jun , Jun Hee Lee , Joon Seok Park
IPC分类号: C07D487/04 , A61P37/00 , A61P35/00 , A61P29/00
摘要: The present invention relates to a pyrazolopyrimidine derivative, or a pharmaceutically acceptable salt thereof. The compound according to the present invention can be usefully used for the prevention or treatment of diseases which are associated with kinase inhibitory actions.
-
公开(公告)号:US20200308177A1
公开(公告)日:2020-10-01
申请号:US16770638
申请日:2018-12-28
发明人: In Woo Kim , Sun Ah Jun , Nam Youn Kim , Jun Hee Lee
IPC分类号: C07D487/04
摘要: The present invention relates to a compound represented by the following Chemical Formula 1, or a pharmaceutically acceptable salt thereof, and the compound according to the present invention can be usefully used for the prevention or treatm ent of diseases which are associated with kinase inhibitory actions.
-
公开(公告)号:US20200299298A1
公开(公告)日:2020-09-24
申请号:US16770642
申请日:2018-12-28
发明人: In Woo Kim , Seung Hwarn Jeong , Nam Youn Kim , Jun Hee Lee
IPC分类号: C07D487/04 , A61P37/00 , A61P35/00
摘要: The present invention relates to a compound represented by the following Chemical Formula 1, or a pharmaceutically acceptable salt thereof, and the compound according to the present invention can be usefully used for the prevention or treatment of diseases which are associated with kinase inhibitory actions.
-
公开(公告)号:US11078206B2
公开(公告)日:2021-08-03
申请号:US16770642
申请日:2018-12-28
发明人: In Woo Kim , Seung Hwarn Jeong , Nam Youn Kim , Jun Hee Lee
IPC分类号: C07D487/04 , A61P37/00 , A61P35/00
摘要: The present invention relates to a compound represented by the following Chemical Formula 1, or a pharmaceutically acceptable salt thereof, and the compound according to the present invention can be usefully used for the prevention or treatment of diseases which are associated with kinase inhibitory actions.
-
公开(公告)号:US20210188854A1
公开(公告)日:2021-06-24
申请号:US16770213
申请日:2018-12-28
发明人: In Woo Kim , Nam Youn Kim , Seung Hwarn Jeong , Bo-Kyoung Kim , Jun Hee Lee
IPC分类号: C07D487/04
摘要: The present invention relates to a compound represented by the following Chemical Formula 1, or a pharmaceutically acceptable salt thereof, and the compound according to the present invention can be usefully used for the prevention or treatment of diseases which are associated with kinase inhibitory actions.
-
公开(公告)号:US20200317673A1
公开(公告)日:2020-10-08
申请号:US16304798
申请日:2017-06-30
发明人: In Woo Kim , Mi Ryeong Han , Jakyung Yoo , Yun Ju Oh , Ji Duck Kim , Nam Youn Kim , Sun Ah Jun , Jun Hee Lee , Joon Seok Park
IPC分类号: C07D487/04 , A61P29/00 , A61P35/00 , A61P37/00
摘要: The present invention relates to a pyrazolopyrimidine derivative, or a pharmaceutically acceptable salt thereof. The compound according to the present invention can be usefully used for the prevention or treatment of diseases which are associated with kinase inhibitory actions.
-
公开(公告)号:US11407754B2
公开(公告)日:2022-08-09
申请号:US16770213
申请日:2018-12-28
发明人: In Woo Kim , Nam Youn Kim , Seung Hwarn Jeong , Bo-Kyoung Kim , Jun Hee Lee
IPC分类号: A61K31/519 , C07D487/04
摘要: The present invention relates to a compound represented by the following Chemical Formula 1, or a pharmaceutically acceptable salt, stereoisomer, or tautomer thereof, and the compound according to the present invention can be usefully used for the prevention or treatment of diseases which are associated with kinase inhibitory actions: wherein, X1 is —NR1—, —O—, or —S—, X2 is CH or N, R1 is C1-5 alkyl, C3-6 cycloalkyl, CH2CHF2, or CH2CF3, wherein the C1-5 alkyl is optionally substituted with one NHC(O)OC(CH3)3 substituent, R2 is H, C1-5 alkyl, or halogen, and R3 is H or C1-5 alkyl.
-
公开(公告)号:US11339167B2
公开(公告)日:2022-05-24
申请号:US16770638
申请日:2018-12-28
发明人: In Woo Kim , Sun Ah Jun , Nam Youn Kim , Jun Hee Lee
IPC分类号: A61K31/519 , C07D487/04
摘要: The present invention relates to a compound represented by the following Chemical Formula 1, or a pharmaceutically acceptable salt, stereoisomer, or tautomer thereof, and the compound according to the present invention can be usefully used for the prevention or treatment of diseases which are associated with kinase inhibitory actions: wherein: R1 is pyrazolyl, isooxazolyl, isothiazolyl, phenyl, or benzothiazolyl, wherein the pyrazolyl, isoxazolyl, isothiazolyl, phenyl, or benzothiazolyl is optionally substituted with one Ra substituent; R2 is H, halogen, CN, or C1-5 alkyl; and Ra is C1-5 alkyl, C1-5 haloalkyl, C1-5 hydroxyalkyl, C3-6 cycloalkyl, tetrahydropyranyl, piperidinyl, or morpholino.
-
公开(公告)号:US20210130358A1
公开(公告)日:2021-05-06
申请号:US16478920
申请日:2018-03-19
发明人: In Woo Kim , Ja Kyung Yoo , Ji Duck Kim , Sun Ah Jun , Jun Hee Lee
IPC分类号: C07D487/04 , C07D519/00
摘要: The present invention relates to a compound represented by the Chemical Formula 1 defined in the present specification, or a pharmaceutically acceptable salt thereof. The compound according to the present invention can be usefully used for the prevention or treatment of diseases which are associated with kinase inhibitory actions.
-
公开(公告)号:US09676714B2
公开(公告)日:2017-06-13
申请号:US15026471
申请日:2014-10-02
发明人: Kyung A Yu , Ji Sung Yoon , Deok Ki Eom , Yeon Im Lee , Hye Ryun Shin , Jun Hee Lee , Ha Nee Seo , Ji Duck Kim , Sang Ho Lee , Chun Ho Lee
IPC分类号: C07D209/30 , C07D403/12 , C07D401/14 , C07D401/06 , C07D401/12 , C07D403/04 , C07D471/04 , C07D209/14 , C07D405/14
CPC分类号: C07D209/30 , C07D209/14 , C07D401/06 , C07D401/12 , C07D401/14 , C07D403/04 , C07D403/12 , C07D405/14 , C07D471/04
摘要: Disclosed are a sulfonylindole derivative useful for the prevention or treatment of peptic ulcer, gastritis or reflux esophagitis, a method of preparing the same, and a pharmaceutical composition containing the same.
-
-
-
-
-
-
-
-
-